Nextgen Sciences

ANN ARBOR, Michigan and LONDON, April 13, 2011 - NextGen Group plc (AIM:NGG) is pleased to announce that its US-subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has launched its plasmabreast25 multiplex protein assay, targeting breast cancer (www.nextgensciences.com/assays/breast.php) biomarker discovery and qualification.